Is the Heperon a Vaccine?

2min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

Vaccine hasn't been rolled out equally, so data is not always available. Even with age, you may see it more often among younger people. As awareness grows, we could sort of hope to get better data over the coming weeks. But it's hard, because decisions have to be made now, right? And the, they're very important, big decisions.

Reports of rare and unusual blood clots have resulted in several vaccine roll outs being paused while scientists scramble to work out if the vaccines are responsible and if so how.

The unusual combination of symptoms, including a low platelet count and clots focussed in the abdomen or brain, seems similar to a rare side effect from treatment with the drug blood thinning drug Heparin - however it is not clear how the vaccines could cause the syndrome.

In this episode of Coronapod we discuss the latest theories and ask how scientists are trying to get to the bottom of this important question. Medical regulators maintain that the benefits of these vaccines significantly outweigh the risks. But as uncertainty spreads, we ponder the wider implications of these reports, including the public perception of risk.

News: How could a COVID vaccine cause blood clots? Scientists race to investigate

Coronapod: How to define rare COVID vaccine side effects

Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.

Hosted on Acast. See acast.com/privacy for more information.